Banbakt Special Precautions

General: The safety and efficacy of intravaginal administration of clindamycin have not been studied in the following populations: pregnant women, breast feeding women, women with impaired liver function, immunodeficiency states or colitis.
Before or after initiation of therapy with Clindamycin (Banbakt) suppositories, other infections including Trichomonas vaginalis, Candida albicans, Chlamydia trachomatis and gonococcal infections may need to be investigated by adequate laboratory tests.
The use of Clindamycin (Banbakt) suppositories may result in the overgrowth of nonsusceptible organisms, particularly yeasts.
Pseudomembranous colitis: The use of clindamycin, as well as other antibacterial agents, can cause diarrhea, and in some cases pseudomembranous colitis, which can be both moderate and life threatening. If the use of Clindamycin (Banbakt) suppositories develops severe or prolonged diarrhea, then the medicinal product should be discontinued, carry out appropriate diagnostic procedures and, if necessary, antibiotic treatment should be prescribed. Medicines that suppress the peristalsis are contraindicated in this case. Clindamycin (Banbakt) suppositories should be used with caution in case of history of colitis caused by antibiotics. In such cases, it is recommended to carefully evaluate the benefits of bacterial vaginosis treatment and the potential risk of pseudomembranous colitis.
Inflammatory bowel disease: Clindamycin is recommended in the form of vaginal suppositories with caution for patients with inflammatory bowel disease, in particular Crohn's disease or nonspecific ulcerative colitis.
Sexual intercourse: Patients should be advised that during therapy with Clindamycin (Banbakt) suppositories sexual intercourse should be avoided. The medicinal product contains ingredients that can reduce the strength of latex or rubber products, such as condoms or birth control vaginal diaphragms (see Interactions). Therefore, the use of such products during and within 72 hours after treatment with Clindamycin (Banbakt) suppositories is not recommended, because its contraceptive efficacy and protective properties from sexually transmitted diseases can be reduced.
Use of products for intravaginal administration: During use of vaginal suppositories Clindamycin (Banbakt) suppositories it is not recommended to use other products intended for intravaginal administration (such as tampons, douching agents).
Effects on Ability to Drive and Use Machines: There are no data that suggests clindamycin affects the ability to drive and use machines.